Glaucoma: Overview
Angle Closure Glaucoma: Treatment
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 12, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Irene Gius1, Luigi Tozzi, Chiara Sofia De Biasi
1From the Department of Ophthalmology, University of Padova, Padova, Italy (Gius); Department of Ophthalmology, Pordenone Hospital, Pordenone, Italy (Tozzi, De Biasi); Department of Ophthalmology, "Ca Foncello" Hospital, Treviso, Italy (Pizzolon); Ophthalmology, Eye Care Clinic, Brescia, Italy (Parolini); Ophthalmology-Surgery Department, Guglielmo da Saliceto Hospital, Piacenza, Italy (Frisina).
This review evaluates different prosthetic iris devices used to treat traumatic aniridia. It compares how well these implants improve vision and appearance, while also noting specific complications associated with different manufacturers.
Area of Science:
Background:
Traumatic aniridia presents significant challenges for restoring visual function and ocular anatomy. Prior research has shown that surgical intervention aims to separate ocular chambers and enhance cosmetic appearance. No prior work had resolved which prosthetic iris device offers the most reliable long-term performance. That uncertainty drove this comprehensive assessment of current surgical options. Existing literature often reports varied success rates depending on the specific implant design utilized. Clinicians frequently struggle to select the appropriate device for complex post-traumatic cases. This gap motivated a systematic evaluation of available prosthetic technologies. Understanding these differences remains vital for optimizing patient care after severe eye injuries.
Purpose Of The Study:
The primary aim of this study is to evaluate the anatomical and functional outcomes of various prosthetic iris devices. Researchers sought to clarify how different implant designs influence surgical success in patients with traumatic aniridia. This investigation addresses the lack of consensus regarding the most effective prosthetic technology. The authors intended to compare performance metrics across multiple manufacturer groups. They focused on identifying specific complications that might affect patient recovery. This work addresses the clinical need for evidence-based guidance in reconstructive eye surgery. The team examined how device choice impacts long-term visual and cosmetic results. Ultimately, the study provides a structured overview of the current state of the art in this field.
Main Methods:
The investigators conducted a systematic review of existing medical literature regarding prosthetic iris devices. They screened 185 potential publications to identify relevant clinical data. Seventy articles met the strict eligibility criteria for inclusion in the final analysis. The team categorized the implants into five distinct subgroups based on the manufacturer or design type. This approach facilitated a direct comparison of anatomical and functional results. Researchers extracted data concerning postoperative complications and visual improvements from each selected study. They focused on identifying variations in performance between Ophtec, Morcher, and HumanOptics products. This methodology ensured a rigorous synthesis of current surgical evidence.
Main Results:
The researchers report that all prosthetic iris devices successfully improved glare and aesthetic appearance postoperatively. Intraocular pressure elevation occurred in 40% of patients within the Morcher device subgroup. Prosthesis dislocation was identified in 39% of cases involving Ophtec implants. These findings represent the strongest evidence regarding device-specific adverse events. The data indicate that while functional benefits are consistent, complication profiles differ significantly by manufacturer. No other device group showed such high rates of these specific complications in the analyzed literature. The study provides a clear comparison of performance metrics across the five identified categories. These results highlight the importance of device selection in managing post-traumatic ocular conditions.
Conclusions:
The authors propose that prosthetic iris devices effectively reduce glare and enhance patient aesthetics. This review indicates that specific manufacturers correlate with distinct postoperative complication profiles. Researchers observed that intraocular pressure elevation occurred more frequently in patients receiving Morcher devices. Prosthesis dislocation appeared as a more common challenge for those treated with Ophtec implants. These findings suggest that surgeons must weigh individual patient needs against known device-specific risks. The study highlights the necessity of tailoring surgical approaches to the underlying ocular trauma. Future clinical decisions should incorporate these comparative outcomes to improve patient safety. This synthesis confirms that prosthetic options provide meaningful functional benefits despite potential adverse events.
The researchers report that patients experienced reduced glare and improved aesthetic outcomes following surgery. These benefits were observed across various prosthetic designs, although specific complications like increased intraocular pressure or device displacement varied significantly between the different manufacturer groups.
The authors categorize devices into five distinct groups, including products from Ophtec BV, Morcher GmbH, and HumanOptics AG. These categories allow for a structured comparison of surgical performance and complication rates across different engineering approaches.
The authors note that the specific choice of implant depends on the patient's preexisting clinical condition following severe trauma. Surgeons must also consider individual functional expectations and aesthetic goals when selecting the most appropriate device for the ocular anatomy.
The study utilizes a systematic review of 70 eligible articles to synthesize data. This approach allows the researchers to aggregate findings from a large body of literature to identify trends in surgical success and adverse events.
The researchers measured postoperative intraocular pressure and the frequency of prosthesis dislocation. They found that 40% of the Morcher group experienced pressure spikes, while 39% of the Ophtec group suffered from device displacement.
The authors suggest that surgeons should carefully evaluate device-specific risks when planning reconstructive procedures. They emphasize that understanding these manufacturer-related differences is vital for managing expectations and improving long-term success in patients with traumatic aniridia.